Market revenue in 2023 | USD 17.7 million |
Market revenue in 2030 | USD 24.4 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 71.19% in 2023. Horizon Databook has segmented the Denmark attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
The competitive market scenario for ADHD in Denmark reflects a dynamic landscape influenced by prevalence, treatment options, and emerging opportunities. With around 5% of school children and approximately 3% of adults exhibiting ADHD symptoms, the market presents a significant demand for effective interventions.
The market encompasses various treatment modalities, including medications and nonpharmacological approaches. As awareness grows, there are opportunities for the development of innovative therapies and diagnostic tools.
Collaborations between healthcare providers, pharmaceutical companies, and research institutions can further enhance the understanding & management of ADHD. The evolving market landscape in Denmark offers potential avenues for advancements in ADHD care and underscores the importance of addressing this prevalent neurodevelopmental disorder.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into Denmark attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account